Janssen Vaccines & Prevention B.V. is part of Johnson & Johnson, one of the biggest and most respected health care companies in the world. They are dedicated to bringing meaningful innovation to global health. Their teams focus on the discovery, development, manufacturing, and marketing of novel vaccines to prevent some of the most devastating and complex infectious diseases. These range from respiratory infections like respiratory syncytial virus (RSV) to human immunodeficiency virus (HIV) and pathogens of global concern, such as Ebola and COVID-19.
In this organization, entrepreneurial people are working in a dynamic culture in which innovation and a 'can do' state of mind are of crucial importance. They are continuously looking for enthusiastic, talented people who have the ambition to develop themselves and can be of value to Janssen. The offices of Janssen Vaccines & Prevention are located in Leiden, The Netherlands.

Department
The Bacterial Vaccine department (BacVac) at Janssen Vaccines & Prevention is working on the discovery and early development of novel vaccines for bacterial infectious diseases. This working process includes ‘state of the art’ vaccine discovery, with subsequent in vivo evaluation of vaccine candidates in animal models for immunogenicity and/or efficacy. In addition, manufacturing processes are established and optimized, and the resulting clinical trial material is evaluated in human clinical studies.